Yen, M., Carlson, S., Wan, S., Qu, X., Bsat, M., Singh, P., Chen, C., Yvon, O., Wolpe, A., Kamat, V., Kohar, V., Wurzenberger, C., Wawersik, S., Economides, K., Blom, D. (2026). Targeting IL-22 activity to the gut epithelium confers disease benefit without provoking skin inflammation 2258200. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkag141.556